
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Oncol.
Sec. Thoracic Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1551644
This article is part of the Research Topic Recent Advances in Radiation Oncology for the Management of Thoracic Malignancies View all 3 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Transcatheter arterial chemoembolization may enhance the local concentration and cytotoxicity of chemotherapeutic drugs and block the blood supply to the tumor, with an expectation to control the tumor, relieve hemoptysis, and prolong survival. This review will introduce the research progression of blood supply to lung cancer, discuss pulmonary artery chemoembolization (PACE) and bronchial artery chemoembolization (BACE) for lung cancer, including their indications and contraindications, operation techniques, efficacy assessments, combined treatments as well as their operating complications and the methods to prevent the adverse event.We will discuss the problems and challenges of percutaneous vascular intervention for lung cancer, such as the uncertainty of blood supply artery for lung cancer, the necessity of high-quality controlled studies, and the best choice for the indications.We hope to explore the direction of transcatheter arterial chemoembolization for lung cancer. The aim of this review is to provide a reference for the practice of chemoembolization by vascular interventional radiology for lung cancer.
Keywords: lung cancer, interventional radiology, Pulmonary Artery, Bronchial artery, Chemoembolization
Received: 26 Dec 2024; Accepted: 25 Mar 2025.
Copyright: © 2025 Zhang and LIU. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yu-Jin LIU, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.